These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12052700)

  • 1. Clickhaler dry powder inhaler: focussed in vitro proof of principle evaluation of a new chemical entity for asthma.
    Thibert R; Parry-Billings M; Shott M
    Int J Pharm; 2002 Jun; 239(1-2):149-56. PubMed ID: 12052700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, development and performance of a novel multidose dry-powder inhaler.
    Parry-Billings M; Boyes RN; Clisby LM; Braithwaite P; Williams S; Harper AE
    Med Device Technol; 1999 Nov; 10(9):24-8, 30, 32-4. PubMed ID: 10724653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST
    Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inspiratory flow rates through a novel dry powder inhaler (Clickhaler) in pediatric patients with asthma.
    Nantel NP; Newhouse MT
    J Aerosol Med; 1999; 12(2):55-8. PubMed ID: 10539707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
    Martin GP; Marriott C; Zeng XM
    Pharm Res; 2007 Feb; 24(2):361-9. PubMed ID: 17177114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal amphotericin B dry powder inhaler: effect of fines on in vitro performance.
    Shah SP; Misra A
    Pharmazie; 2004 Oct; 59(10):812-3. PubMed ID: 15544064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.
    Xu Z; Mansour HM; Mulder T; McLean R; Langridge J; Hickey AJ
    J Pharm Sci; 2010 Aug; 99(8):3398-414. PubMed ID: 20198688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance.
    Young PM; Chan HK; Chiou H; Edge S; Tee TH; Traini D
    J Pharm Sci; 2007 May; 96(5):1331-41. PubMed ID: 17455362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of particle morphology on the triboelectrification in dry powder inhalers.
    Murtomaa M; Mellin V; Harjunen P; Lankinen T; Laine E; Lehto VP
    Int J Pharm; 2004 Sep; 282(1-2):107-14. PubMed ID: 15336386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate.
    Nolan LM; Li J; Tajber L; Corrigan OI; Healy AM
    Int J Pharm; 2011 Feb; 405(1-2):36-46. PubMed ID: 21129460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma.
    Bisgaard H; Klug B; Sumby BS; Burnell PK
    Eur Respir J; 1998 May; 11(5):1111-5. PubMed ID: 9648964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of formoterol from a novel multi-dose inhaler Airmax.
    Zeng XM; Jones S; O'Leary D; Phelan M; Colledge J
    Respir Med; 2002 Jun; 96(6):397-403. PubMed ID: 12117038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery performance of the mometasone furoate dry powder inhaler.
    Yang TT; Li S; Wyka B; Kenyon D
    J Aerosol Med; 2001; 14(4):487-94. PubMed ID: 11791689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Easyhaler--ideal dry powder inhaler].
    Andrzej E; Małgorzata BE
    Pol Merkur Lekarski; 2010 Apr; 28(166):307-10. PubMed ID: 20491343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the relative bioavailability of salbutamol to the lungs following inhalation from dry powder inhaler formulations containing drug substance manufactured by supercritical fluids and micronization.
    Richardson CH; de Matas M; Hosker H; Mukherjee R; Wong I; Chrystyn H
    Pharm Res; 2007 Nov; 24(11):2008-17. PubMed ID: 17510755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler.
    Buttini F; Pasquali I; Brambilla G; Copelli D; Alberi MD; Balducci AG; Bettini R; Sisti V
    Pharm Res; 2016 Mar; 33(3):701-15. PubMed ID: 26572643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of dry powder inhaler design, formulation, and performance.
    Newman SP; Busse WW
    Respir Med; 2002 May; 96(5):293-304. PubMed ID: 12113378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.